Related Experiment Video

Updated: Aug 24, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Current concepts in the antithrombotic management of non-ST-elevation acute coronary syndromes

David E Kandzari1

  • 1Division of Cardiology, Duke Clinical Research Unit, 2400 Pratt Street, Room 7063, Durham, NC 27705, USA. kandz002@mc.duke.edu

Current Cardiology Reports
|June 9, 2004
PubMed

Insights

Novel antithrombotic therapies improve outcomes for acute coronary syndromes (ACS). Despite proven benefits, many high-risk patients with non-ST-segment elevation ACS (NSTE ACS) still undertreat. Future research will refine personalized treatment strategies.

Area of Science:

  • Cardiology
  • Thrombosis Research

Background:

  • Thrombosis is central to acute coronary syndromes (ACS).
  • Recent advancements focus on antiplatelet and anticoagulant therapies for non-ST-segment elevation ACS (NSTE ACS).
  • Early invasive strategies are key components of NSTE ACS management.

Purpose of the Study:

  • To review the pathophysiologic basis of antithrombotic therapies in ACS.
  • To examine recent clinical trial outcomes in NSTE ACS management.
  • To outline future research directions for optimizing patient care.

Main Methods:

  • Review of current literature and clinical trial data.
  • Analysis of pathophysiologic mechanisms underlying thrombosis in ACS.
  • Discussion of risk stratification and treatment timing in NSTE ACS.

Main Results:

  • Current antithrombotic therapies significantly reduce death and myocardial infarction in ACS.
  • Despite efficacy, undertreatment persists in high-risk NSTE ACS patients.
  • Ongoing trials aim to personalize treatment based on individual risk and procedural availability.

Conclusions:

  • Antithrombotic therapies are crucial for managing ACS, particularly NSTE ACS.
  • Improving treatment access and adherence for high-risk NSTE ACS patients is essential.
  • Future research should focus on tailored therapeutic strategies and revascularization timing.

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...